Sinopharm

Chinese vaccine gets HSA nod

Sign up now: Get ST's newsletters delivered to your inbox

Several healthcare groups have received approval to import China's Sinopharm vaccine, including IHH Healthcare and Raffles Medical.
This will likely see it becoming the fourth Covid-19 vaccine available here, as Singapore ramps up nationwide vaccination rates in order to ease Covid-19 restrictions and reopen its economy.
See more on